CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
TC BioPharm Holdings PLC is a biotechnology business based in the US. TC BioPharm shares (TCBP.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.43 – a decrease of 5.8% over the previous day. TC BioPharm employs 60 staff and has a market cap (total outstanding shares value) of $4.1 million.
CIBC Investor's Edge
Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Note: The dollar amounts in the table below are in Canadian dollars.
|Revenue TTM||$3.8 million|
|Gross profit TTM||$3.8 million|
|Return on assets TTM||-78.54%|
|Return on equity TTM||0%|
|Market capitalisation||$4.1 million|
TTM: trailing 12 months
We're not expecting TC BioPharm to pay a dividend over the next 12 months.
TC BioPharm's shares were split on a 1:50 basis on 20 November 2022. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TC BioPharm shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for TC BioPharm shares which in turn could have impacted TC BioPharm's share price.
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. .
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.Read more…
Steps to owning and managing Yoshitsu Co. stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Cerberus Cyber Sentinel stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Fresh Vine Wine, Inc stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing DGX with 24-hour and historical pricing before you buy.
Everything we know about the Nuvectis Pharma IPO plus information on how to buy in.
Steps to owning and managing BuzzFeed, Inc stocks, with 24-hour and historical pricing before you buy.
These are the best renewable energy stocks to buy now in Canada.
Steps to owning and managing ADMA with 24-hour and historical pricing before you buy.
Steps to owning and managing DY with 24-hour and historical pricing before you buy.
Steps to owning and managing VICI with 24-hour and historical pricing before you buy.
You must be logged in to post a comment.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.